Table 3 HRs used to reflect the effectiveness of finerenone [13]

The onset of eGFR decrease < 15 mL/min/1.73 m² sustained over at least 4 weeks

0.82 (0.67–1.01)

Progression to dialysis

0.87 (0.67–1.12)

Progression to kidney transplant

1.00^a (1.00–1.00)

CV death

0.86 (0.68–1.08)

Renal death, CKD 5 w/o RRT

1.03 (0.15–7.31)

First modelled CV event^b

0.87 (0.74–1.02)

Subsequent CV event^b

0.95 (0.70–1.30)

Hyperkalemia leading to hospitalization

2.71 (1.60–4.60)

Hyperkalemia not leading to hospitalization

1.92 (1.67–2.21)

New onset of atrial fibrillation/atrial flutter

0.71 (0.53–0.94)